LeonardCGlassMD

PubMed

• 1 citations
  A Patient-Driven Approach to Manage Mealtime Insulin Titration: Tools From the AUTONOMY Study
  Allison Camacho, Jennal Johnson, Jeffrey S. Bonner, Leonard C. Glass> ;The Diabetes Educator. 2016 Apr 11
• 1 citations
  Evaluation of a patient self-directed mealtime insulin titration algorithm: a US payer perspective
  Bradley H. Curtis, Sarah E Curtis, Daniel R Murphy, James C Gahn, Sinem Perk, Harry J. Smolen, James F. Murray, Nana Numapau, Jeffrey S. Bonner, Rong Liu, Jennal Johns...> ;Journal of Medical Economics. 2016 Feb 1
• 3 citations
  Insulin Lispro with Continuous Subcutaneous Insulin Infusion is Safe and Effective in Patients with Type 2 Diabetes: A Randomized Crossover Trial of Insulin Lispro Ver...
  James Thrasher, Anuj Bhargava, Tina M. Rees, Tao Wang, Cristina B. Guzman, Leonard C. Glass> ;Endocrine Practice. 2015 Mar 1
• Response to Comment on Edelman et al. AUTONOMY: The First Randomized Trial Comparing Two Patient-Driven Approaches to Initiate and Titrate Prandial Insulin Lispro in T...
  Steve Edelman, Rong Liu, Jennal Johnson, Leonard C. Glass> ;Diabetes Care. 2014 Dec 1
• 32 citations
  AUTONOMY: The First Randomized Trial Comparing Two Patient-Driven Approaches to Initiate and Titrate Prandial Insulin Lispro in Type 2 Diabetes
  Steve Edelman, Rong Liu, Jennal Johnson, Leonard C. Glass> ;Diabetes Care. 2014 Aug 1
• The Effects of LY2405319, an FGF21 Analog, in Obese Human Subjects with Type 2 Diabetes.
  Gaich, G.,Chien, J. Y.,Fu, H.,Glass, L. C.,Deeg, M. A.,Holland, W. L.,Kharitonenkov, A.,Bumol, T.,Schilske, H. K.,Moller, D. E.> ;Cell Metab.. 2013 Sep 3
• 54 citations
  Baseline factors associated with glycemic control and weight loss when exenatide twice daily is added to optimized insulin glargine in patients with type 2 diabetes.
  Julio Rosenstock, Sylvia K. Shenouda, Richard M. Bergenstal, John B. Buse, Leonard C. Glass, Cory R. Heilmann, Anita Y.M. Kwan, Leigh MacConell, Byron J. Hoogwerf> ;Diabetes Care. 2012 May 1
• 14-Day In Vitro Chemical Stability of Insulin Lispro in the MiniMed Paradigm Pump.
  Sharrow, S.D., Glass, L.C., Dobbins, M.A.> ;Diabetes Technol Ther. 2012 Mar
• 411 citations
  Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial.
  John B. Buse, Richard M. Bergenstal, Leonard C. Glass, Cory R. Heilmann, Michelle S. Lewis, Anita Y.M. Kwan, Byron J. Hoogwerf, Julio Rosenstock> ;Annals of Internal Medicine. 2011 Jan 18
• 84 citations
  Effects of Exenatide Plus Rosiglitazone on β-Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin
  Ralph A. DeFronzo, Curtis L Triplitt, Yongming Qu, Michelle S. Lewis, David G. Maggs, Leonard C. Glass> ;Diabetes Care. 2010 May 1
• 79 citations
  Effects of Exenatide Combined with Lifestyle Modification in Patients with Type 2 Diabetes
  Caroline M. Apovian, Richard M. Bergenstal, Robert Cuddihy, Yongming Qu, Sheila M. Lenox, Michelle S. Lewis, Leonard C. Glass> ;The American Journal of Medicine. 2010 May 1
• 13 citations
  Model-based assessment of insulin sensitivity of glucose disposal and endogenous glucose production from double-tracer oral glucose tolerance test
  Karl Thomaseth, Alessandra Pavan, Rachele Berria, Leonard C. Glass, Ralph A. DeFronzo, Amalia Gastaldelli> ;Computer Methods and Programs in Biomedicine. 2008 Feb 1
• 65 citations
  Reduction in hematocrit and hemoglobin following pioglitazone treatment is not hemodilutional in Type II diabetes mellitus.
  Rachele Berria, Leonard C. Glass, Archana Mahankali, Y. Miyazaki, Adriana Monroy, E De Filippis, Kenneth Cusi, Eugenio Cersosimo, Ralph A. DeFronzo, Amalia Gastaldelli> ;Clinical Pharmacology and Therapeutics. 2007 Sep 1
• 104 citations
  Effects of peroxisome proliferator-activated receptor (PPAR)-α and PPAR-γ agonists on glucose and lipid metabolism in patients with type 2 diabetes mellitus
  Mandeep Bajaj, Swangjit Suraamornkul, Lou J. Hardies, Leonard C. Glass, Nicolas Musi, Ralph A. DeFronzo> ;Diabetologia. 2007 May 23
• 20 citations
  Comparison of Glargine Insulin Versus Rosiglitazone Addition in Poorly Controlled Type 2 Diabetic Patients on Metformin Plus Sulfonylurea
  Curtis L Triplitt, Leonard C. Glass, Yoshiniro Miyazaki, Estela Wajcberg, Amalia Gastaldelli, Elena A. De Filippis, Eugenio Cersosimo, Ralph A. DeFronzo> ;Diabetes Care. 2006 Nov 1
• 281 citations
  Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.
  Mandeep Bajaj, Swangjit Suraamornkul, Paul K. Piper, Lou J. Hardies, Leonard C. Glass, Eugenio Cersosimo, Thongchai Pratipanawatr, Yoshinori Miyazaki, Ralph A. DeFronzo> ;The Journal of Clinical Endocrinology and Metabolism. 2004 Jan 1
• 4 citations
  Images in clinical medicine. Pituitary apoplexy.
  Leonard C Glass> ;The New England Journal of Medicine. 2003 Nov 20
• 36 citations
  Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis.
  Ele Ferrannini, Amalia Gastaldelli, Masafumi Matsuda, Yoshinori Miyazaki, Maura Pettiti, Leonard C. Glass, Ralph A. DeFronzo> ;The Journal of Clinical Endocrinology and Metabolism. 2003 Jul 1
• 220 citations
  Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes.
  Mandeep Bajaj, Swangjit Suraamornkul, Thongchai Pratipanawatr, Lou J. Hardies, Wilailak Pratipanawatr, Leonard C. Glass, Eugenio Cersosimo, Yoshinori Miyazaki, Ralph A...> ;Diabetes. 2003 Jun 1
• 188 citations
  Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus
  Yoshinori Miyazaki, Leonard C. Glass, Curtis L Triplitt, Estela Wajcberg, Lawrence J. Mandarino, Ralph A. DeFronzo> ;American Journal of Physiology. Endocrinology and Metabolism. 2002 Dec 1
• 61 citations
  Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals.
  Masafumi Matsuda, Ralph A. DeFronzo, Leonard C. Glass, Agostino Consoli, Mauro Giordano, Peter Bressler, Stefano DelPrato> ;Metabolism. 2002 Sep 1
• 3 citations
  Effect of misoprostol (PGE1) on glucose metabolism in type-2-diabetic and control subjects.
  N. A. Lee, Masafumi Matsuda, P. Bressler, Thongchai Pratipanawatr, Leonard C. Glass, Lawrence J. Mandarino, Ralph A. DeFronzo> ;Diabetes, Obesity & Metabolism. 2002 May 1
• 211 citations
  Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients
  Y. Miyazaki, Leonard C. Glass, Curtis L Triplitt, Masafumi Matsuda, Kenneth Cusi, Archana Mahankali, Srikanth Mahankali, Lawrence J. Mandarino, Ralph A. DeFronzo> ;Diabetologia. 2001 Dec 1
• 309 citations
  Improved Glycemic Control and Enhanced Insulin Sensitivity in Type 2 Diabetic Subjects Treated With Pioglitazone
  Yoshinori Miyazaki, Archana Mahankali, Masafumi Matsuda, Leonard C. Glass, Srikanth Mahankali, Eleuterio Ferrannini, Kenneth Cusi, Lawrence J. Mandarino, Ralph A. DeFr...> ;Diabetes Care. 2001 Apr 1
• 305 citations
  Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycaemia.
  E Wright, JL Scism-Bacon, LC Glass> ;International Journal of Clinical Practice. 2006 Mar 1
• Join now to see all